Ex vivo-activated human macrophages kill chronic lymphocytic leukemia cells in the presence of rituximab: mechanism of antibody-dependent cellular cytotoxicity and impact of human serum. [electronic resource]
- Journal of immunotherapy (Hagerstown, Md. : 1997)
- 388-97 p. digital